Skip to main content
Premium Trial:

Request an Annual Quote

The Race to be a Winner

James Watson's Double Helix, his account of the discovery of the structure of DNA, was first published in 1968, and the Guardian's Tim Radford takes a look back at it. "I have now read the book four or five times … and it remains startling, and in unexpected ways, startlingly good," Radford writes. He notes that neither Francis Crick nor Maurice Wilkins wanted the book to be published, and adds that while the passage of time has smoothed over some of the objections, "the passages about Rosalind Franklin remain as cruel as ever."

"But it remains a compelling book: compelling precisely because of some of the things that caused offence at the time," he says. "It presents science as a messy, confused but collegiate enterprise in which any advance is dependent on other people's achievements, but that nevertheless rewards only winners; and it presents Crick and Watson as two people who set out to be winners."

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.